- Home
- REE vs AVTX Comparison
REE vs AVTX Comparison
Compare REE & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- AVTX
- Stock Information
- Founded
- REE 2011
- AVTX 2011
- Country
- REE Israel
- AVTX United States
- Employees
- REE N/A
- AVTX N/A
- Industry
- REE Auto Manufacturing
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- AVTX Health Care
- Exchange
- REE Nasdaq
- AVTX Nasdaq
- Market Cap
- REE 70.5M
- AVTX 57.4M
- IPO Year
- REE N/A
- AVTX 2015
- Fundamental
- Price
- REE $3.01
- AVTX $4.25
- Analyst Decision
- REE Strong Buy
- AVTX Strong Buy
- Analyst Count
- REE 3
- AVTX 6
- Target Price
- REE $12.50
- AVTX $34.20
- AVG Volume (30 Days)
- REE 90.1K
- AVTX 66.4K
- Earning Date
- REE 05-29-2025
- AVTX 05-20-2025
- Dividend Yield
- REE N/A
- AVTX N/A
- EPS Growth
- REE N/A
- AVTX N/A
- EPS
- REE N/A
- AVTX N/A
- Revenue
- REE $626,000.00
- AVTX $441,000.00
- Revenue This Year
- REE N/A
- AVTX N/A
- Revenue Next Year
- REE $18,744.14
- AVTX N/A
- P/E Ratio
- REE N/A
- AVTX N/A
- Revenue Growth
- REE N/A
- AVTX N/A
- 52 Week Low
- REE $2.31
- AVTX $4.15
- 52 Week High
- REE $11.72
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- REE 47.76
- AVTX 31.02
- Support Level
- REE $2.68
- AVTX $4.80
- Resistance Level
- REE $3.25
- AVTX $5.26
- Average True Range (ATR)
- REE 0.25
- AVTX 0.45
- MACD
- REE 0.12
- AVTX 0.03
- Stochastic Oscillator
- REE 63.08
- AVTX 11.96
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).